Rare diseases
Investigational molecules
Locations
Study on the Effectiveness and Safety of Guselkumab and Ustekinumab for Patients with Moderate to Severe Crohn's Disease
PolandStudy on the Effects of TAK-881 and Hyaluronidase in Adults with Primary Immunodeficiency Diseases
PolandStudy Comparing BP11 and Omalizumab for Patients with Chronic Spontaneous Urticaria Resistant to H1 Antihistamines
PolandStudy on the Long-Term Safety and Efficacy of Nemolizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis
PolandStudy of RVU120 and Ruxolitinib for Patients with Intermediate or High-Risk Myelofibrosis
PolandStudy on the Long-Term Safety and Effectiveness of Nemolizumab for Patients with Prurigo Nodularis
PolandStudy of trastuzumab deruxtecan treatment in patients with advanced HER2-positive breast cancer with or without brain metastases
PolandStudy on the Long-Term Effects of TEV-48574 (Duvakitug) for Adults with Moderate to Severe Ulcerative Colitis or Crohn's Disease
PolandStudy on Donanemab, Florbetapir, and Flortaucipir for Patients with Early Alzheimer's Disease
PolandStudy on BHV-7000 for Patients with Generalized Tonic-clonic Seizures in Idiopathic Generalized Epilepsy
PolandStudy of dupilumab added to inhaled corticosteroids and long-acting beta-agonists compared to high-dose inhaled therapy in adolescents and adults with uncontrolled asthma
PolandStudy on Barzolvolimab for Patients with Chronic Spontaneous Urticaria Unresponsive to H1 Antihistamines
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.
